Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Weiss, TW; Aichinger, J; Huber, K; Speidl, WS; Watzinger, N; Zweiker, R; Alber, HF.
Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr. 2016; 128(11-12):450-457 Doi: 10.1007/s00508-016-1016-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG


Co-Autor*innen der Med Uni Graz
Zweiker Robert

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

The protective effect of dual antiplatelet therapy (DAPT) following acute coronary syndrome is undisputed, but its duration is subject of debate. Several studies show that prolonged therapy provides a clinical benefit in patients following acute coronary syndrome. The aim of this position paper authored by Austrian experts is to outline the current evidence and provide an overview of recent studies. It is also intended to serve as a practical guide to identify those patients who may benefit from prolonged DAPT.
Find related publications in this database (using NLM MeSH Indexing)
Aspirin - administration & dosage
Aspirin - standards
Austria -
Drug Administration Schedule -
Evidence-Based Medicine - standards
Humans -
Myocardial Infarction - drug therapy
Myocardial Infarction - prevention & control
Platelet Aggregation Inhibitors - administration & dosage
Platelet Aggregation Inhibitors - standards
Practice Guidelines as Topic -
Purinergic P2Y Receptor Antagonists - administration & dosage
Purinergic P2Y Receptor Antagonists - standards
Secondary Prevention - standards
Treatment Outcome -

Find related publications in this database (Keywords)
P2Y(12) inhibitor
Acute coronary syndrome
Myocardial infarction
© Med Uni Graz Impressum